https://www.selleckchem.com/products/ms-275.html
04). Relative increases in TFx (ΔTFx 1.86 ± 2.22) were associated with disease progression, whereas relative decreases in TFx (ΔTFx 0.53 ± 0.36) were associated with disease regression ( 0.00001). A ≥15% increase in TFx relative to baseline during treatment was associated with an over 90-fold increased likelihood of clinical progression (odds ratio = 90.67, 95% confidence interval = 8.30-990.16, = 0.0002). TFx and SCNA amplitude were significantly positively correlated throughout sampling ( ≤ 0.002). Longitudinal changes in AH-deriv